News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
850,218 Results
Type
Article (86523)
Company Profile (642)
Press Release (763051)
Multimedia
Podcasts (134)
Webinars (18)
Section
Business (232633)
Career Advice (4123)
Deals (39739)
Drug Delivery (127)
Drug Development (90961)
Employer Resources (198)
FDA (18112)
Job Trends (17358)
News (396415)
Policy (39785)
Tag
Academia (3000)
Academic (1)
Accelerated approval (11)
Adcomms (25)
Allergies (99)
Alliances (56925)
ALS (114)
Alzheimer's disease (1542)
Antibody-drug conjugate (ADC) (168)
Approvals (18098)
Artificial intelligence (337)
Autoimmune disease (30)
Automation (19)
Bankruptcy (403)
Best Places to Work (12603)
BIOSECURE Act (21)
Biosimilars (129)
Biotechnology (438)
Bladder cancer (94)
Brain cancer (35)
Breast cancer (370)
Cancer (2912)
Cardiovascular disease (221)
Career advice (3531)
Career pathing (32)
CAR-T (198)
CDC (36)
Cell therapy (528)
Cervical cancer (23)
Clinical research (74084)
Collaboration (1029)
Company closure (3)
Compensation (687)
Complete response letters (25)
COVID-19 (2890)
CRISPR (62)
C-suite (331)
Cystic fibrosis (118)
Data (3008)
Decentralized trials (2)
Denatured (51)
Depression (68)
Diabetes (351)
Diagnostics (6948)
Digital health (23)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (141)
Drug pricing (138)
Drug shortages (32)
Duchenne muscular dystrophy (129)
Earnings (97309)
Editorial (45)
Employer branding (25)
Employer resources (168)
Events (130887)
Executive appointments (847)
FDA (19771)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (942)
Gene editing (137)
Generative AI (25)
Gene therapy (398)
GLP-1 (890)
Government (5223)
Grass and pollen (4)
Guidances (181)
Healthcare (20864)
HIV (40)
Huntington's disease (32)
IgA nephropathy (41)
Immunology and inflammation (154)
Immuno-oncology (10)
Indications (39)
Infectious disease (3064)
Inflammatory bowel disease (160)
Inflation Reduction Act (13)
Influenza (63)
Intellectual property (121)
Interviews (811)
IPO (17888)
IRA (49)
Job creations (5193)
Job search strategy (2861)
Kidney cancer (13)
Labor market (56)
Layoffs (568)
Leadership (20)
Legal (10109)
Liver cancer (85)
Longevity (11)
Lung cancer (410)
Lymphoma (211)
Machine learning (11)
Management (64)
Manufacturing (406)
MASH (93)
Medical device (14681)
Medtech (14686)
Mergers & acquisitions (22537)
Metabolic disorders (900)
Multiple sclerosis (99)
NASH (23)
Neurodegenerative disease (119)
Neuropsychiatric disorders (34)
Neuroscience (2245)
NextGen: Class of 2025 (7667)
Non-profit (5084)
Now hiring (48)
Obesity (459)
Opinion (277)
Ovarian cancer (103)
Pain (109)
Pancreatic cancer (122)
Parkinson's disease (190)
Partnered (22)
Patents (304)
Patient recruitment (167)
Peanut (54)
People (65556)
Pharmaceutical (132)
Pharmacy benefit managers (24)
Phase I (22873)
Phase II (32193)
Phase III (24218)
Pipeline (1646)
Policy (218)
Postmarket research (3549)
Preclinical (10327)
Press Release (72)
Prostate cancer (142)
Psychedelics (42)
Radiopharmaceuticals (271)
Rare diseases (471)
Real estate (7398)
Recruiting (76)
Regulatory (27042)
Reports (61)
Research institute (2657)
Resumes & cover letters (649)
Rett syndrome (9)
RNA editing (9)
RSV (51)
Schizophrenia (93)
Series A (165)
Series B (109)
Service/supplier (27)
Sickle cell disease (63)
Special edition (22)
Spinal muscular atrophy (165)
Sponsored (37)
Startups (4303)
State (2)
Stomach cancer (15)
Supply chain (77)
Tariffs (58)
The Weekly (81)
Vaccines (876)
Venture capital (57)
Weight loss (297)
Women's health (52)
Worklife (19)
Date
Today (92)
Last 7 days (352)
Last 30 days (1840)
Last 365 days (31378)
2025 (16875)
2024 (37021)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (68)
Alaska (7)
Arizona (277)
Arkansas (14)
Asia (50409)
Australia (8864)
California (7560)
Canada (2374)
China (677)
Colorado (327)
Connecticut (323)
Delaware (196)
Europe (115444)
Florida (1121)
Georgia (255)
Hawaii (2)
Idaho (66)
Illinois (700)
India (29)
Indiana (372)
Iowa (17)
Japan (230)
Kansas (116)
Kentucky (30)
Louisiana (16)
Maine (69)
Maryland (1057)
Massachusetts (5710)
Michigan (258)
Minnesota (469)
Mississippi (3)
Missouri (92)
Montana (29)
Nebraska (26)
Nevada (83)
New Hampshire (69)
New Jersey (2108)
New Mexico (28)
New York (2103)
North Carolina (1192)
North Dakota (8)
Northern California (3290)
Ohio (241)
Oklahoma (17)
Oregon (46)
Pennsylvania (1627)
Puerto Rico (17)
Rhode Island (38)
South America (1654)
South Carolina (34)
South Dakota (1)
Southern California (2792)
Tennessee (126)
Texas (1150)
United States (28311)
Utah (221)
Virginia (195)
Washington D.C. (76)
Washington State (658)
West Virginia (4)
Wisconsin (69)
850,218 Results for "biospace inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
GLP-1
BioSpace
Presents the World Atlas of GLP-1s
Eli Lilly and Novo Nordisk are in a global battle for dominance in the weight loss space.
BioSpace
takes a look at the territory covered and what’s to come.
March 26, 2025
·
2 min read
·
Annalee Armstrong
Layoff Tracker
Ventus “Recalibrates” to Support Mid-Stage Trials
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
July 16, 2025
·
159 min read
·
BioSpace Editorial Staff
Job Trends
Getting Jobs Outside of Major Biopharma Hubs Proves Tough,
BioSpace
Finds
Over 80% of those living outside of biopharma’s biggest hubs, like San Diego or Boston, have a tough time finding work, according to a
BioSpace
LinkedIn poll. Biopharma professionals in Oregon and Connecticut and a
BioSpace
recruitment manager share their insights on this issue.
February 27, 2025
·
6 min read
·
Angela Gabriel
Job Trends
BioSpace
Showcases Life Sciences Hubs in 2025 Hotbed Maps
BioSpace
has revealed its 2025 Hotbed Maps, showcasing nine regional hot spots for life sciences activity.
January 21, 2025
·
1 min read
·
Chantal Dresner
Job Trends
BioSpace
Announces 2025 Best Places to Work in Biopharma
BioSpace
has named 50 biopharma companies to its 2025 Best Places to Work list, including Moderna and Sutro Biopharma, whose executives share what makes their organizations special.
November 12, 2024
·
6 min read
·
Angela Gabriel
Career Advice
Job Ghosting, Ghost Jobs Top Job Hunt Complaints,
BioSpace
Finds
A
BioSpace
LinkedIn poll found that job ghosting and ghost jobs are the biggest pet peeves for applicants now. Recruitment Manager Greg Clouse offers advice on dealing with them.
February 13, 2025
·
5 min read
·
Angela Gabriel
IN PARTNERSHIP WITH DIA
Balancing Protection and Inclusion: The Evolution of Women in Clinical Trials
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses the evolution of women’s inclusion in clinical trials with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
March 27, 2025
·
1 min read
·
Lori Ellis
Job Trends
Over Half of Biopharma Professionals Work More Hours Than Average US Workers,
BioSpace
Finds
Although U.S. full-time employees worked an average of 42.9 hours weekly last year, according to Gallup, that wasn’t true for most
BioSpace
LinkedIn poll respondents. A Karius HR executive discusses a few potential reasons for the longer workweeks.
April 3, 2025
·
3 min read
·
Angela Gabriel
Job Trends
Report: 2025 U.S. Life Sciences Salary Report
March 25, 2025
·
1 min read
·
BioSpace Insights
Business
Navigating Funding Freezes and AI Frontiers
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis discusses key themes from BIO and DIA, including the funding environment, with Rich Daly, CEO of Catalyst Pharmaceuticals, Peter Ronco, CEO of Emmes Corporation, and Phil Vanek, founder of Redline Bio Advisors.
June 20, 2025
·
1 min read
·
Lori Ellis
1 of 85,022
Next
